VEGF‐Positive Mass‐Forming Intrahepatic Cholangiocarcinoma: New Subtype Based on Radiological and Molecular Pathological Analysis
Hepatology Research · 2026-06 · 56 (6) · 976-987
DOI: 10.1111/hepr.70151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatology Research, online erschienen am 04.03.2026. Verfasst von Junya Tsuzaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Keio University School of Medicine, Tokyo, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Aim
Among mass‐forming (MF) type intrahepatic cholangiocarcinoma (ICC), approximately 20%–30% are hypervascular on imaging and are associated with improved prognosis. However, the molecular background based on gene expression of this entity remains unclear.
Methods
We retrospectively analyzed 109 patients with MF‐type ICC resected at the National Cancer Center Hospital, Japan. Preoperative dynamic computed tomography (CT) images were available for 48 cases. Based on the late‐arterial‐phase enhancement area (EA) and the relative enhancement ratio (RER), 17 were classified as hypervascular ICC (H‐ICC, EA ≥ 50%), 21 as hypovascular ICC (h‐ICC, EA < 50%, RER ≥ 1), and 10 as nonvascular ICC (N‐ICC, EA < 50%, RER < 1). We compared group‐wise arterial vessel density (AVD), then profiled angiogenesis genes to identify a suitable immunohistochemical marker.
Results
The H‐ICC group had a better prognosis than h‐ICC ( P = 0.024) and N‐ICC ( P = 0.002). H‐ICC also had a higher AVD than other groups ( P < 0.001). Among the angiogenesis‐related genes, vascular endothelial growth factor A (VEGFA) exhibited the strongest correlation with EA ( P = 0.012), and H‐ICC exhibited higher VEGF positivity than other groups ( P = 0.022). The survival and immunostaining profiles of h‐ICC closely resembled those of N‐ICC. ROC analysis revealed that a VEGF staining positivity of 70% was the optimal cut‐off for identifying H‐ICC.
Conclusions
H‐ICC is characterized by hyperenhancement occupying ≥ 50% of the tumor area on dynamic CT, high AVD, and elevated VEGFA expression. These findings support a distinct clinicopathological subset identifiable by LAP enhancement and VEGF immunostaining.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Keio University School of Medicine, Tokyo, Japan.
- Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
- Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
- Division of Molecular Pathology, Tochigi Cancer Center Research Institute, Tochigi, Japan.
- Department of Radiology, Dokkyo Medical University School of Medicine, Tochigi, Japan.
- Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan.
ORCID-Profile: Junya Tsuzaki, Naoto Kubota, Shigeyoshi Soga, Masahiro Jinzaki, Hidenori Ojima
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Tsuzaki, J., Kubota, N., Soga, S., Arai, Y., Shibata, T., Esaki, M., Jinzaki, M., & Ojima, H. (2026). VEGF‐Positive Mass‐Forming Intrahepatic Cholangiocarcinoma: New Subtype Based on Radiological and Molecular Pathological Analysis. Hepatology Research, 56(6), 976-987. https://doi.org/10.1111/hepr.70151
Vancouver
Tsuzaki J, Kubota N, Soga S, Arai Y, Shibata T, Esaki M, et al. VEGF‐Positive Mass‐Forming Intrahepatic Cholangiocarcinoma: New Subtype Based on Radiological and Molecular Pathological Analysis. Hepatology Research. 2026;56(6):976-987. doi:10.1111/hepr.70151
BibTeX
@article{Tsuzaki2026,
author = {Tsuzaki, Junya and Kubota, Naoto and Soga, Shigeyoshi and Arai, Yasuhito and Shibata, Tatsuhiro and Esaki, Minoru and Jinzaki, Masahiro and Ojima, Hidenori},
title = {VEGF‐Positive Mass‐Forming Intrahepatic Cholangiocarcinoma: New Subtype Based on Radiological and Molecular Pathological Analysis},
journal = {Hepatology Research},
year = {2026},
volume = {56},
number = {6},
pages = {976--987},
doi = {10.1111/hepr.70151}
}
EUVIMED